User login
- /content/rozanolixizumab-may-offer-new-treatment-paradigm-itp
- /fedprac/article/203513/bleeding-disorders/rozanolixizumab-may-offer-new-treatment-paradigm-itp
- /hematologynews/article/203513/bleeding-disorders/rozanolixizumab-may-offer-new-treatment-paradigm
- /internalmedicinenews/article/203513/bleeding-disorders/rozanolixizumab-may-offer-new-treatment
- /hematology-oncology/article/203513/bleeding-disorders/rozanolixizumab-may-offer-new-treatment
- /hematologytimes/article/203513/bleeding-disorders/rozanolixizumab-may-offer-new-treatment-paradigm
- /internalmedicine/article/203513/bleeding-disorders/rozanolixizumab-may-offer-new-treatment-paradigm